Altimmune Reports Positive 48-Week Phase 2b Result...
Category : Clinical Trial Update 1 June 2026Altimmune has announced new 48-week results from its IMPACT Phase 2b trial evaluating pemvidutide, a...
Clinical Trial Update
GSK and Ionis Report Positive Phase 3 Results for...
Category : Clinical Trial Update 1 June 2026New Hope for Patients Living with Chronic Hepatitis B Chronic hepatitis B (CHB) remains one of th...
MediciNova Completes Phase 2 Trial for MN-001 in N...
Category : Clinical Trial Update 27 May 2026MediciNova Reaches Important Clinical Milestone MediciNova has announced the completion of the la...
Jade Biosciences Doses First Patient in Phase 1 Tr...
Category : Clinical Trial Update 27 May 2026Jade Biosciences Starts Human Testing for JADE201 Jade Biosciences has announced that the first p...
A Single Infusion Drug That Might Lower Cholestero...
Category : Clinical Trial Update 26 May 2026Eli Lilly and Company shared new Phase 1b results for a drug called VERVE-102. The main idea is p...
Latest Newsletter Post
-
GSK and Ionis Report Positive Phase..
1 June 2026
-
Altimmune Reports Positive 48-Week..
1 June 2026
-
Jade Biosciences Doses First Patien..
27 May 2026
-
MediciNova Completes Phase 2 Trial..
27 May 2026
-
Ascletis Tweaks Its Oral GLP-1 Stra..
26 May 2026
